Nucleic acid aptamers: Research tools in disease diagnostics and therapeutics

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Santosh, Baby ^a   Yadava, Pramod K ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; APTAMER; ARC 1905; ARC 19499; AS 1411; BAX 499; E 10030; EGAPTIVON PEGOL; GLUTATHIONE; GLYCOPROTEIN GP 120; NOX A 12; NOX E 36; NOX H 94; NU 172; NUCLEIC ACID; PEGAPTANIB; PEGNIVACOGIN; PEPTIDE APTAMER; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ACUTE GRANULOCYTIC LEUKEMIA; ANEMIA; BIOSENSOR; CANCER DIAGNOSIS; CANCER THERAPY; GENE EXPRESSION; HEMOPHILIA; INFECTION; NEOPLASM; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; RANDOMIZATION; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RIBOSWITCH; THROMBOTIC THROMBOCYTOPENIC PURPURA; ANIMAL; COMBINATORIAL CHEMISTRY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC USE; DISEASES; HUMAN; MEDICAL RESEARCH;

ANIMALS; APTAMERS, NUCLEOTIDE; BIOMEDICAL RESEARCH; DIAGNOSTIC TECHNIQUES AND PROCEDURES; DISEASE; HUMANS; SELEX APTAMER TECHNIQUE;

EID: 84904111483     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/540451     Document Type: Review

References (99)

1. Ellington A. D., Szostak J. W., In vitro selection of RNA molecules that bind specific ligands. Nature 1990 346 6287 818 822 10.1038/346818a0 2-s2.0-0025074907 (Pubitemid 20272100)
2. Tuerk C., Gold L., Systemic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990 249 4968 505 510 10.1126/science.2200121 2-s2.0-0025194307
3. Bunka D. H. J., Stockley P. G., Aptamers come of age-at last. Nature Reviews Microbiology 2006 4 8 588 596 10.1038/nrmicro1458 2-s2.0-33747164245 (Pubitemid 44317021)
4. Stoltenburg R., Reinemann C., Strehlitz B., SELEX-a (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomolecular Engineering 2007 24 4 381 403 10.1016/j.bioeng.2007.06.001 2-s2.0-34548551398 (Pubitemid 47391579)
5. Hermann T., Patel D. J., Adaptive recognition by nucleic acid aptamers. Science 2000 287 5454 820 825 10.1126/science.287.5454.820 2-s2.0-0034603154 (Pubitemid 30084318)
6. Gold L., Oligonucleotides as research, diagnostic, and therapeutic agents. The Journal of Biological Chemistry 1995 270 23 13581 13584 10.1074/jbc.270.23.13581 2-s2.0-0029031094
7. Pollard J., Bell S. D., Ellington A. D., Design, synthesis, and amplification of DNA pools for in vitro selection. Current Protocols in Nucleic Acid Chemistry 2001 Chapter 9, Unit 9.2 John Wiley & Sons
8. Kulbachinskiy A. V., Methods for selection of aptamers to protein targets. Biochemistry 2007 72 13 1505 1518 10.1134/S000629790713007X 2-s2.0-38349089990
9. Yang Y., Yang D., Schluesener H. J., Zhang Z., Advances in SELEX and application of aptamers in the central nervous system. Biomolecular Engineering 2007 24 6 583 592 10.1016/j.bioeng.2007.06.003 2-s2.0-36248951185 (Pubitemid 350137885)
10. Hwang S.-Y., Sun H.-Y., Lee K.-H., Oh B.-H., Cha Y. J., Kim B. H., Yoo J., 5′-Triphosphate-RNA-independent activation of RIG-I via RNA aptamer with enhanced antiviral activity. Nucleic Acids Research 2012 40 6 2724 2733 10.1093/nar/gkr1098 2-s2.0-84859336804
11. Lee Y. J., Lee S.-W., Regression of hepatocarcinoma cells using RNA aptamer specific to alpha-fetoprotein. Biochemical and Biophysical Research Communications 2012 417 1 521 527 10.1016/j.bbrc.2011.11.153 2-s2.0-84855803788
12. Bala J., Bhaskar A., Varshney A., Singh A. K., Dey S., Yadava P., In vitro selected RNA aptamer recognizing glutathione induces ROS-mediated apoptosis in the human breast cancer cell line MCF 7. RNA Biology 2011 8 1 101 111 10.4161/rna.V.I.14116 2-s2.0-79952208880
13. Brockstedt U., Uzarowska A., Montpetit A., Pfau W., Labuda D., In vitro evolution of RNA aptamers recognizing carcinogenic aromatic amines. Biochemical and Biophysical Research Communications 2004 313 4 1004 1008 10.1016/j.bbrc.2003.12.030 2-s2.0-0346728743 (Pubitemid 38050092)
14. Xu W., Ellington A. D., Anti-peptide aptamers recognize amino acid sequence and bind a protein epitope. Proceedings of the National Academy of Sciences of the United States of America 1996 93 15 7475 7480 10.1073/pnas.93.15.7475 2-s2.0-0029847929 (Pubitemid 26277059)
15. Gronewold T. M. A., Baumgartner A., Hierer J., Sierra S., Blind M., Schäfer F., Blümer J., Tillmann T., Kiwitz A., Kaiser R., Zabe-Kühn M., Quandt E., Famulok M., Kinetic binding analysis of aptamers targeting HIV-1 proteins by a combination of a Microbalance Array and Mass Spectrometry (MAMS). Journal of Proteome Research 2009 8 7 3568 3577 10.1021/pr900265r 2-s2.0-67650376538
16. Zhou J., Li H., Li S., Zaia J., Rossi J. J., Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy. Molecular Therapy 2008 16 8 1481 1489 10.1038/mt.2008.92 2-s2.0-48349105059
17. Ulrich H., Ippolito J. E., Pagán O. R., Eterović V. A., Hann R. M., Shi H., Lis J. T., Eldefrawi M. E., Hess G. P., In vitro selection of RNA molecules that displace cocaine from the membrane-bound nicotinic acetylcholine receptor. Proceedings of the National Academy of Sciences of the United States of America 1998 95 24 14051 14056 10.1073/pnas.95.24.14051 2-s2.0-0032564455 (Pubitemid 28549318)
18. Rentmeister A., Bill A., Wahle T., Walter J., Famulok M., RNA aptamers selectively modulate protein recruitment to the cytoplasmic domain of β -secretase BACE1 in vitro. RNA 2006 12 9 1650 1660 10.1261/rna.126306 2-s2.0-33748164764 (Pubitemid 44316030)
19. Li N., Nguyen H. H., Byrom M., Ellington A. D., Inhibition of cell proliferation by an anti-EGFR aptamer. PLoS ONE 2011 6 6 e20299 10.1371/journal.pone.0022011 2-s2.0-79960333300
20. Barfod A., Persson T., Lindh J., In vitro selection of RNA aptamers against a conserved region of the Plasmodium falciparum erythrocyte membrane protein 1. Parasitology Research 2009 105 6 1557 1566 10.1007/s00436-009-1583-x 2-s2.0-70350238646
21. Pagratis N. C., Bell C., Chang Y. F., Jennings S., Fitzwater T., Jellinek D., Dang C., Potent 2′-amino-, and 2′-fluoro-2′- deoxyribonucleotide RNA inhibitors of keratinocyte growth factor. Nature Biotechnology 1997 15 1 68 73 10.1038/nbt0197-68 2-s2.0-0031012128
22. O'Codnnell D., Koenig A., Jennings S., Hicke B., Han H., Fitzwater T., Chang Y., Varki N., Parma D., Varki A., Calcium-dependent oligonucleotide antagonists specific for L-selectin. Proceedings of the National Academy of Sciences of the United States of America 1996 93 12 5883 5887 10.1073/pnas.93.12.5883 2-s2.0-15844389533 (Pubitemid 26190772)
23. 2 complexed to a high-affinity RNA aptamer. Proceedings of the National Academy of Sciences of the United States of America 2003 100 16 9268 9273 10.1073/pnas.1632011100 2-s2.0-0042925463 (Pubitemid 37033918)
24. McNamara J. O. II, Andrechek E. R., Wang Y., Viles K. D., Rempel R. E., Gilboa E., Sullenger B. A., Giangrande P. H., Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nature Biotechnology 2006 24 8 1005 1015 10.1038/nbt1223 2-s2.0-33747031960 (Pubitemid 44215395)
25. Lee S. K., Park M. W., Yang E. G., Yu J., Jeong S., An RNA aptamer that binds to the β -catenin interaction domain of TCF-1 protein. Biochemical and Biophysical Research Communications 2005 327 1 294 299 10.1016/j.bbrc.2004. 12.011 2-s2.0-11144223772 (Pubitemid 40051383)
26. Hicke B. J., Marion C., Chang Y. F., Gould T., Lynott C. K., Parma D., Schmidt P. G., Warren S., Tenascin-C aptamers are generated using tumor cells and purified protein. The Journal of Biological Chemistry 2001 276 52 48644 48654 10.1074/jbc.M104651200 2-s2.0-0035966106
27. Hicke B. J., Stephens A. W., Gould T., Chang Y., Lynott C. K., Heil J., Borkowski S., Hilger C., Cook G., Warren S., Schmidt P. G., Tumor targeting by an aptamer. Journal of Nuclear Medicine 2006 47 4 668 678 2-s2.0-33745108827 (Pubitemid 46768469)
28. Ohuchi S. P., Ohtsu T., Nakamura Y., Selection of RNA aptamers against recombinant transforming growth factor- β type III receptor displayed on cell surface. Biochimie 2006 88 7 897 904 10.1016/j.biochi.2006.02.004 2-s2.0-33746495033 (Pubitemid 44142173)
29. Lee J.-H., Canny M. D., De Erkenez A., Krilleke D., Ng Y.-S., Shima D. T., Pardi A., Jucker F., A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165. Proceedings of the National Academy of Sciences of the United States of America 2005 102 52 18902 18907 10.1073/pnas.0509069102 2-s2.0-30044436689 (Pubitemid 43049539)
30. Bardeesy N., Pelletier J., Overlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product. Nucleic Acids Research 1998 26 7 1784 1792 10.1093/nar/26.7.1784 2-s2.0-0032052293 (Pubitemid 28291817)
31. Lee H. K., Choi Y. S., Park Y. A., Jeong S., Modulation of oncogenic transcription and alternative splicing by β -catenin and an RNA aptamer in colon cancer cells. Cancer Research 2006 66 21 10560 10566 10.1158/0008-5472. CAN-06-2526 2-s2.0-33751269933 (Pubitemid 44799779)
32. Gilbert B. A., Sha M., Wathen S. T., Rando R. R., RNA aptamers that specifically bind to a K ras-derived farnesylated peptide. Bioorganic & Medicinal Chemistry 1997 5 6 1115 1122 10.1016/S0968-0896(97)00047-3 2-s2.0-0030917170 (Pubitemid 27264838)
33. Ylera F., Lurz R., Erdmann V. A., Fürste J. P., Selection of RNA aptamers to the alzheimer's disease amyloid peptide. Biochemical and Biophysical Research Communications 2002 290 5 1583 1588 10.1006/bbrc.2002.6354 2-s2.0-0036289319 (Pubitemid 34687439)
34. Li S., Xu H., Ding H., Huang Y., Cao X., Yang G., Li J., Xie Z., Meng Y., Li X., Zhao Q., Shen B., Shao N., Identification of an aptamer targeting hnRNP A1 by tissue slide-based SELEX. The Journal of Pathology 2009 218 3 327 336 10.1002/path.2543 2-s2.0-67650088525
35. Liu Z., Duan J.-H., Song Y.-M., Ma J., Wang F.-D., Lu X., Yang X.-D., Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro. Journal of Translational Medicine 2012 10 1, article 148 10.1186/1479-5876-10-148 2-s2.0-84867754001
36. Han S. R., Lee S.-W., In vitro selection of RNA aptamer specific to salmonella typhimurium. Journal of Microbiology and Biotechnology 2013 23 6 878 884 10.4014/jmb.1212.12033 2-s2.0-84879128465
37. Murphy M. B., Fuller S. T., Richardson P. M., Doyle S. A., An improved method for the in vitro evolution of aptamers and applications in protein detection and purification. Nucleic Acids Research 2003 31 18, article e110 10.1093/nar/gng110 2-s2.0-1042296535
38. Song Y., Zhu Z., An Y., Zhang W., Zhang H., Liu D., Yu C., Duan W., Yang C. J., Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture. Analytical Chemistry 2013 85 8 4141 4149 10.1021/ac400366b 2-s2.0-84876264381
39. Ferreira C. S. M., Matthews C. S., Missailidis S., DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers. Tumor Biology 2006 27 6 289 301 10.1159/000096085 2-s2.0-33750445311 (Pubitemid 44646223)
40. Slupianek A., Dasgupta Y., Ren S.-Y., Gurdek E., Donlin M., Nieborowska-Skorska M., Fleury F., Skorski T., Targeting RAD51 phosphotyrosine-315 to prevent unfaithful recombination repair in BCR-ABL1 leukemia. Blood 2011 118 4 1062 1068
41. Rérole A.-L., Gobbo J., De Thonel A., Schmitt E., Pais De Barros J. P., Hammann A., Lanneau D., Fourmaux E., Deminov O., Micheau O., Lagrost L., Colas P., Kroemer G., Garrido C., Peptides and aptamers targeting HSP70: a novel approach for anticancer chemotherapy. Cancer Research 2011 71 2 484 495 10.1158/0008-5472.CAN-10-1443 2-s2.0-78751478982
42. Butz K., Denk C., Ullmann A., Scheffner M., Hoppe-Seyler F., Induction of apoptosis in human papillomavirus-positive cancer cells by peptide aptamers targeting the viral E6 oncoprotein. Proceedings of the National Academy of Sciences of the United States of America 2000 97 12 6693 6697 10.1073/pnas.110538897 2-s2.0-0034612296 (Pubitemid 30412776)
43. Kunz C., Borghouts C., Buerger C., Groner B., Peptide aptamers with binding specificity for the intracellular domain of the ErbB2 receptor interfere with AKT signaling and sensitize breast cancer cells to taxol. Molecular Cancer Research 2006 4 12 983 986 10.1158/1541-7786.MCR-06-0046 2-s2.0-33846329836 (Pubitemid 46121556)
44. Richardson F. C., Tennant B. C., Meyer D. J., Richardson K. A., Mann P. C., Mcginty G. R., Wolf J. L., Zack P. M., Bendele R. A., An evaluation of the toxicities of 2′-fluorouridine and 2′- fluorocytidine-HCl in F344 rats and woodchucks (Marmota monax). Toxicologic Pathology 1999 27 6 607 617 10.1177/019262339902700601 2-s2.0-0032701241
45. Shannon Pendergrast P. S., Nicholas Marsh H. N., Grate D., Healy J. M., Stanton M., Nucleic acid aptamers for target validation and therapeutic applications. Journal of Biomolecular Techniques 2005 16 3 224 234 2-s2.0-33644850350
46. Tucker C. E., Chen L., Judkins M. B., Farmer J. A., Gill S. C., Drolet D. W., Detection and plasma pharmacokinetics of an anti-vascular endothelial growth factor oligonucleotide-aptamer (NX1838) in rhesus monkeys. Journal of Chromatography B: Biomedical Sciences and Applications 1999 732 1 203 212 10.1016/S0378-4347(99)00285-6 2-s2.0-0032876515 (Pubitemid 29421761)
47. Lin Y., Qiu Q., Gill S. C., Jayasena S. D., Modified RNA sequence pools for in vitro selection. Nucleic Acids Research 1994 22 24 5229 5234 10.1093/nar/22.24.5229 2-s2.0-0028641549
48. Reyderman L., Stavchansky S., Pharmacokinetics and biodistribution of a nucleotide-based thrombin inhibitor in rats. Pharmaceutical Research 1998 15 6 904 910 10.1023/A:1011980716659 2-s2.0-0031782408 (Pubitemid 28307833)
49. Stickler D. J., King J. B., Winters C., Morris S. L., Blockage of urethral catheters by bacterial biofilms. Journal of Infection 1993 27 2 133 135 10.1016/0163-4453(93)94620-Q 2-s2.0-0027437686 (Pubitemid 23295336)
50. Savory N., Lednor D., Tsukakoshi K., Abe K., Yoshida W., Ferri S., Jones B. V., Ikebukuro K., In silico maturation of binding-specificity of DNA aptamers against Proteus mirabilis. Biotechnology and Bioengineering 2013 110 10 2573 2580 10.1002/bit.24922 2-s2.0-84876667096
51. Pastor F., Soldevilla M. M., Villanueva H., Kolonias D., Inoges S., De Cerio A. L., Kandzia R., Klimyuk V., Gleba Y., Gilboa E., Bendandi M., CD28 aptamers as powerful immune response modulators. Molecular Therapy-Nucleic Acids 2013 2, article e98 10.1038/mtna.2013.26 2-s2.0-84880161343
52. Winkler W. C., Breaker R. R., Regulation of bacterial gene expression by riboswitches. Annual Review of Microbiology 2005 59 487 517 10.1146/annurev. micro.59.030804.121336 2-s2.0-27144527479 (Pubitemid 41507440)
53. Tucker B. J., Breaker R. R., Riboswitches as versatile gene control elements. Current Opinion in Structural Biology 2005 15 3 342 348 10.1016/j.sbi.2005.05.003 2-s2.0-20444478991 (Pubitemid 40826454)
54. Matylla-Kulinska K., Boots J. L., Zimmermann B., Schroeder R., Finding aptamers and small ribozymes in unexpected places. Wiley Interdisciplinary Reviews: RNA 2012 3 1 73 91 10.1002/wrna.105 2-s2.0-84867591926
55. Montange R. K., Batey R. T., Riboswitches: emerging themes in RNA structure and function. Annual Review of Biophysics 2008 37 117 133 10.1146/annurev.biophys.37.032807.130000 2-s2.0-48249104039
56. Wan Y., Kim Y., Li N., Cho S. K., Bachoo R., Ellington A. D., Iqbal S. M., Surface-immobilized aptamers for cancer cell isolation and microscopic cytology. Cancer Research 2010 70 22 9371 9380 10.1158/0008-5472.CAN-10-0568 2-s2.0-78549238601
57. Zhang P., Zhao N., Zeng Z., Feng Y., Tung C., Chang C., Zu Y., Using an RNA aptamer probe for flow cytometry detection of CD30-expressing lymphoma cells. Laboratory Investigation 2009 89 12 1423 1432 10.1038/labinvest.2009.113 2-s2.0-70549112254
58. Stead S. L., Ashwin H., Johnston B., Tarbin J. A., Sharman M., Kay J., Keely B. J., An RNA-aptamer-based assay for the detection and analysis of malachite green and leucomalachite green residues in fish tissue. Analytical Chemistry 2010 82 7 2652 2660 10.1021/ac902226v 2-s2.0-77950451235
59. Flinders J., DeFina S. C., Brackett D. M., Baugh C., Wilson C., Dieckmann T., Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex. ChemBioChem 2004 5 1 62 72 10.1002/cbic.200300701 2-s2.0-0346457132 (Pubitemid 38095022)
60. Dua P., Kim S., Lee D.-K., Nucleic acid aptamers targeting cell-surface proteins. Methods 2011 54 2 215 225 10.1016/j.ymeth.2011.02.002 2-s2.0-79958744392
61. Shangguan D., Cao Z., Meng L., Mallikaratchy P., Sefah K., Wang H., Li Y., Tan W., Cell-specific aptamer probes for membrane protein elucidation in cancer cells. Journal of Proteome Research 2008 7 5 2133 2139 10.1021/pr700894d 2-s2.0-46049086644
62. Li Y., Lee H. J., Corn R. M., Detection of protein biomarkers using RNA aptamer microarrays and enzymatically amplified surface plasmon resonance imaging. Analytical Chemistry 2007 79 3 1082 1088 10.1021/ac061849m 2-s2.0-33846992303
63. Lauridsen L. H., Veedu R. N., Nucleic acid aptamers against biotoxins: a new paradigm toward the treatment and diagnostic approach. Nucleic Acid Therapeutics 2012 22 6 371 379 10.1089/nat.2012.0377 2-s2.0-84870567743
64. Tok J. B.-H., Fischer N. O., Single microbead SELEX for efficient ssDNA aptamer generation against botulinum neurotoxin. Chemical Communications 2008 16 1883 1885 10.1039/b717936g 2-s2.0-41849089323 (Pubitemid 351503452)
65. Bruno J. G., Kiel J. L., Use of magnetic beads in selection and detection of biotoxin aptamers by electrochemiluminescence and enzymatic methods. BioTechniques 2002 32 1 178 183 2-s2.0-0036140250 (Pubitemid 34052765)
66. Hesselberth J. R., Miller D., Robertus J., Ellington A. D., In vitro selection of RNA molecules that inhibit the activity of ricin A-chain. Journal of Biological Chemistry 2000 275 7 4937 4942 10.1074/jbc.275.7.4937 2-s2.0-0034681355 (Pubitemid 30108888)
67. Lamont E. A., He L., Warriner K., Labuza T. P., Sreevatsan S., A single DNA aptamer functions as a biosensor for ricin. Analyst 2011 136 19 3884 3895 10.1039/c1an15352h 2-s2.0-80052538637
68. Bruno J. G., Kiel J. L., In vitro selection of DNA aptamers to anthrax spores with electrochemiluminescence detection. Biosensors and Bioelectronics 1999 14 5 457 464 10.1016/S0956-5663(99)00028-7 2-s2.0-0033620595 (Pubitemid 29333570)
69. Win M. N., Klein J. S., Smolke C. D., Codeine-binding RNA aptamers and rapid determination of their binding constants using a direct coupling surface plasmon resonance assay. Nucleic Acids Research 2006 34 19 5670 5682 10.1093/nar/gkl718 2-s2.0-33750968498 (Pubitemid 44742454)
70. Pothoulakis G., Ceroni F., Reeve B., Ellis T., The Spinach RNA Aptamer as a characterization tool for synthetic biology. ACS Synthetic Biology 2014 3 3 182 187 10.1021/sb400089c
71. Kent A. D., Spiropulos N. G., Heemstra J. M., General approach for engineering small-molecule-binding DNA split aptamers. Analytical Chemistry 2013 85 20 9916 9923 10.1021/ac402500n
72. McCauley T. G., Hamaguchi N., Stanton M., Aptamer-based biosensor arrays for detection and quantification of biological macromolecules. Analytical Biochemistry 2003 319 2 244 250 10.1016/S0003-2697(03)00297-5 2-s2.0-0038167143 (Pubitemid 36842733)
73. Thompson K. M., Syrett H. A., Knudsen S. M., Ellington A. D., Group I aptazymes as genetic regulatory switches. BMC Biotechnology 2002 2, article 21 10.1186/1472-6750-2-21 2-s2.0-0642367619 (Pubitemid 38846434)
74. Hanson S., Berthelot K., Fink B., McCarthy J. E. G., Suess B., Tetracycline-aptamer-mediated translational regulation in yeast. Molecular Microbiology 2003 49 6 1627 1637 10.1046/j.1365-2958.2003.03656.x 2-s2.0-0141677751 (Pubitemid 37153521)
75. Jeong S., Lee H. K., Kim M. Y., Use of RNA aptamers for the modulation of cancer cell signaling. Methods in Molecular Biology 2009 542 363 377 10.1007/978-1-59745-561-9-20 2-s2.0-67650299971
76. Sivanesan S., Howell M. D., Didonato C. J., Singh R. N., Antisense oligonucleotide mediated therapy of spinal muscular atrophy. Translational Neuroscience 2013 4 1 1 7 10.2478/s13380-013-0109-2 2-s2.0-84874915156
77. Soontornworajit B., Wang Y., Nucleic acid aptamers for clinical diagnosis: cell detection and molecular imaging. Analytical and Bioanalytical Chemistry 2011 399 4 1591 1599 10.1007/s00216-010-4559-x 2-s2.0-79451472116
78. Jayasena S. D., Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clinical Chemistry 1999 45 9 1628 1650 2-s2.0-0032860385 (Pubitemid 29419030)
79. Germer K., Leonard M., Zhang X., RNA aptamers and their therapeutic and diagnostic applications. International Journal of Biochemistry and Molecular Biology 2013 4 1 27 40 2-s2.0-84876025119
80. Ng E. W. M., Shima D. T., Calias P., Cunningham E. T. Jr., Guyer D. R., Adamis A. P., Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nature Reviews Drug Discovery 2006 5 2 123 132 10.1038/nrd1955 2-s2.0-33645095226
81. Mongelard F., Bouvet P., AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia. Current Opinion in Molecular Therapeutics 2010 12 1 107 114 2-s2.0-76749169748
82. Sinha G., Regado's aptamer lines up against anticoagulants. Nature Biotechnology 2013 31 12 1060
83. Jilma-Stohlawetz P., Gilbert J. C., Gorczyca M. E., Knöbl P., Jilma B., A dose ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombo-cytopenic purpura. Thrombosis and Haemostasis 2011 106 3 539 547 10.1160/TH11-02-0069 2-s2.0-80052350022
84. Keefe A. D., Pai S., Ellington A., Aptamers as therapeutics. Nature Reviews Drug Discovery 2010 9 7 537 550 10.1038/nrd3141 2-s2.0-77954220072
85. Nakamura Y., Ishiguro A., Miyakawa S., RNA plasticity and selectivity applicable to therapeutics and novel biosensor development. Genes to Cells 2012 17 5 344 364 10.1111/j.1365-2443.2012.01596.x 2-s2.0-84859881576
86. Akiyama H., Kachi S., Silva R. L. E., Umeda N., Hackett S. F., McCauley D., McCauley T., Zoltoski A., Epstein D. M., Campochiaro P. A., Intraocular injection of an aptamer that binds PDGF-B: a potential treatment for proliferative retinopathies. Journal of Cellular Physiology 2006 207 2 407 412 10.1002/jcp.20583 2-s2.0-33645689371
87. Darisipudi M. N., Kulkarni O. P., Sayyed S. G., Ryu M., Migliorini A., Sagrinati C., Parente E., Vater A., Eulberg D., Klussmann S., Romagnani P., Anders H.-J., Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease. The American Journal of Pathology 2011 179 1 116 124 10.1016/j.ajpath.2011.03.004 2-s2.0-80052435113
88. Schwoebel F., van Eijk L. T., Zboralski D., Sell S., Buchner K., Maasch C., Purschke W. G., Humphrey M., Zöllner S., Eulberg D., Morich F., Pickkers P., Klussmann S., The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys. Blood 2013 121 12 2311 2315 10.1182/blood-2012-09-456756 2-s2.0-84877930663
89. Parunov L. A., Fadeeva O. A., Balandina A. N., Soshitova N. P., Kopylov K. G., Kumskova M. A., Gilbert J. C., Schaub R. G., Mcginness K. E., Ataullakhanov F. I., Panteleev M. A., Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: changing clot size by targeting extrinsic pathway initiation. Journal of Thrombosis and Haemostasis 2011 9 9 1825 1834 10.1111/j.1538-7836.2011.04412.x 2-s2.0-80052415230
90. Chen C.-H. B., Chernis G. A., Hoang V. Q., Landgraf R., Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3. Proceedings of the National Academy of Sciences of the United States of America 2003 100 16 9226 9231 10.1073/pnas.1332660100 2-s2.0-0041923790 (Pubitemid 37033911)
91. Lupold S. E., Hicke B. J., Lin Y., Coffey D. S., Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Research 2002 62 14 4029 4033 2-s2.0-0037099536 (Pubitemid 34791070)
92. Chu T. C., Twu K. Y., Ellington A. D., Levy M., Aptamer mediated siRNA delivery. Nucleic Acids Research 2006 34 10, article e73 10.1093/nar/gkl388 2-s2.0-33745128099 (Pubitemid 44540445)
93. Ni X., Zhang Y., Ribas J., Chowdhury W. H., Castanares M., Zhang Z., Laiho M., DeWeese T. L., Lupold S. E., Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts. The Journal of Clinical Investigation 2011 121 6 2383 2390 10.1172/JCI45109 2-s2.0-79957920185
94. Zhou J., Shu Y., Guo P., Smith D. D., Rossi J. J., Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition. Methods 2011 54 2 284 294 10.1016/j.ymeth.2010.12.039 2-s2.0-79958716788
95. Seiwert S. D., Nahreini T. S., Aigner S., Ahn N. G., Uhlenbeck O. C., RNA aptamers as pathway-specific MAP kinase inhibitors. Chemistry & Biology 2000 7 11 833 843 10.1016/S1074-5521(00)00032-6 2-s2.0-0033764406
96. Luster A. D., Alon R., von Andrian U. H., Immune cell migration in inflammation: present and future therapeutic targets. Nature Immunology 2005 6 12 1182 1190 10.1038/ni1275 2-s2.0-30044447736 (Pubitemid 43045626)
97. Zhao W., Loh W., Droujinine I. A., Teo W., Kumar N., Schafer S., Cui C. H., Zhang L., Sarkar D., Karnik R., Karp J. M., Mimicking the inflammatory cell adhesion cascade by nucleic acid aptamer programmed cell-cell interactions. FASEB Journal 2011 25 9 3045 3056 10.1096/fj.10-178384 2-s2.0-79961208879
98. Xu D., Shi H., Composite RNA aptamers as functional mimics of proteins. Nucleic Acids Research 2009 37 9, article e71 10.1093/nar/gkp243 2-s2.0-66249128638
99. Paige J. S., Wu K. Y., Jaffrey S. R., RNA mimics of green fluorescent protein. Science 2011 333 6042 642 646 10.1126/science.1207339 2-s2.0-79960959180